Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
12/02/2022* -- Results Q4 2022 -- 3.13 --
12/02/2022* 17:00 EST Earnings Call Q4 2022 -- -- --
08/31/2022 -- Results Q3 2022 3.19 3.23 -1.18%
08/31/2022 17:00 EST Earnings Call Q3 2022 -- -- --
06/02/2022 -- Results Q2 2022 3.24 3.43 -5.49%
06/02/2022 17:00 EST Earnings Call Q2 2022 -- -- --
03/03/2022 -- Results Q1 2022 3.24 3.11 4.15%
03/03/2022 17:00 EST Earnings Call Q1 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 12/02/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/31/2022
Beat/Miss Upgrade
Return Since -4.09%
Last FQE 07/31/2022
Next FQE 10/31/2022

Profile

Edit
Cooper Companies operates two units: CooperVision and CooperSurgical. Accounting for approximately 75% of total sales, CooperVision is the the second-largest player in the oligopolistic contact lens market. Over 50% of CooperVision's sales are in international territories. The second unit, CooperSurgical, develops and manufactures diagnostic and surgical products for gynecologists and obstetricians, including the Paragard IUD, which Cooper acquired from Teva in 2017.
URL https://www.coopercos.com
Investor Relations URL https://investor.coopercos.com/
HQ State/Province California
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Mid Cap/Blend
Next Earnings Release Dec. 02, 2022 (est.)
Last Earnings Release Aug. 31, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jul. 26, 2022

Dividends

Dividend Per Share (TTM) 0.06
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.0152
Yield to Sector 0.0117
Yield to Industry 0.0242
Last Dividend Amt. 0.03
Dividend Frequency Semi-Annually
Last Ex-Dividend Date Jul. 26, 2022
Yield (TTM) 0.02%
Forward Yield 0.02%
Payout Ratio 0.70%
Cash Payout Ratio 0.57%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-17.18%
30.40%
24.59%
16.84%
26.27%
13.10%
15.33%
-34.18%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-21.61%
59.29%
-12.42%
222.6%
-41.84%
-24.64%
19.84%
-50.83%
-9.50%
--
--
--
--
28.09%
434.1%
143.1%
-51.32%
-26.69%
1.04%
102.4%
12.62%
53.69%
139.4%
-24.86%
-46.23%
32.33%
-32.38%
2.42%
-0.65%
0.53%
28.66%
30.72%
10.42%
As of September 23, 2022.

Profile

Edit
Cooper Companies operates two units: CooperVision and CooperSurgical. Accounting for approximately 75% of total sales, CooperVision is the the second-largest player in the oligopolistic contact lens market. Over 50% of CooperVision's sales are in international territories. The second unit, CooperSurgical, develops and manufactures diagnostic and surgical products for gynecologists and obstetricians, including the Paragard IUD, which Cooper acquired from Teva in 2017.
URL https://www.coopercos.com
Investor Relations URL https://investor.coopercos.com/
HQ State/Province California
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Mid Cap/Blend
Next Earnings Release Dec. 02, 2022 (est.)
Last Earnings Release Aug. 31, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jul. 26, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
FID1710 126.70M USD 4.38%
FID1700 126.70M USD 4.38%
UTRN 2.959M USD 3.98%
TMFM 6.021M USD 3.08%
SMVFX 83.36M USD 3.04%
BKUS 181662.0 USD 2.19%
PFUT 132450.0 USD 2.09%
GDOC 1.767M USD 1.88%
FVUSA04AZ9 69.51M USD 1.41%
RRMGX 382.91M USD 1.40%
OWSMX 75.25M USD 0.98%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter COO Tweets